The pathogenesis and clinical features of diabetic cardiomyopathy have been well-studied
in the past decade, but effective approaches to prevent and treat this disease are limited …

Most screening programs to identify individuals at risk for type 1 diabetes have targeted
relatives of people living with the disease to improve yield and feasibility. However,∼ 90 …

Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at
the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay …

Type 1 diabetes is a chronic, immune-mediated disease characterised by the destruction of
insulin-producing cells. Standardised registry data show that type 1 diabetes incidence has …

Type 1 diabetes mellitus (T1DM), also known as autoimmune diabetes, is a chronic disease
characterized by insulin deficiency due to pancreatic β-cell loss and leads to …

Type 1 diabetes is diagnosed at the end of a prodrome of β-cell autoimmunity. The disease
is most likely triggered at an early age by autoantibodies primarily directed against insulin or …

Importance Type 1 diabetes usually has a preclinical phase identified by circulating islet
autoantibodies, but the rate of progression to diabetes after seroconversion to islet …

Type 1 diabetes (T1D) results from immune‐mediated loss of pancreatic beta cells leading
to insulin deficiency. It is the most common form of diabetes in children, and its incidence is …

Importance Public health screening for type 1 diabetes in its presymptomatic stages may
reduce disease severity and burden on a population level. Objective To determine the …

Insights from prospective, longitudinal studies of individuals at risk for developing type 1
diabetes have demonstrated that the disease is a continuum that progresses sequentially at …